Eculizumab As a Treatment for Gemcitabine Induced Thrombotic Microangiopathy: A Case Report of Partial Response in a Patient with Pancreatic Adenocarcinoma
Author Type(s)
Faculty, Resident/Fellow
Document Type
Abstract
Publication Date
11-2-2023
DOI
10.1182/blood-2023-187877
Journal Title
Blood
Department
Medicine
Recommended Citation
Khurshid, A., Vegunta, R., & Steinberg, A. (2023). Eculizumab As a Treatment for Gemcitabine Induced Thrombotic Microangiopathy: A Case Report of Partial Response in a Patient with Pancreatic Adenocarcinoma. Blood, 142 (Suppl. 1), 5440. https://doi.org/10.1182/blood-2023-187877
COinS
